Paul Bruinenberg
Impact in
-
- Cystic Fibrosis Research Advances
- Inhalation and Respiratory Drug Delivery
- Tracheal and airway disorders
- Neonatal Respiratory Health Research
- Pharmaceutical Science top 10%
- Advanced Drug Delivery Systems
Papers in
-
- Cystic Fibrosis Research Advances 10
- Inhalation and Respiratory Drug Delivery 7
- Neonatal Respiratory Health Research 3
-
- Antibiotics Pharmacokinetics and Efficacy 4
- Co-authors
- David J. Serisier (9 shared papers)Diana Bilton (5 shared papers)David Cipolla (5 shared papers)John Kolbe (3 shared papers)Hugh Greville (3 shared papers)Anthony De Soyza (2 shared papers)Igor Gonda (3 shared papers)Philip J. Thompson (2 shared papers)
- Journals
- Antimicrobial Agents and Chemotherapy (3 papers)Journal of Cystic Fibrosis (2 papers)British Journal of Clinical Pharmacology (1 paper)Thorax (1 paper)Pneumologie (1 paper)
- Partner nations
- United StatesAustraliaUnited Kingdom
In The Last Decade
Paul Bruinenberg
14 papers receiving 251 citations
Peers
Comparison fields: 5 of 35
- Pulmonary and Respiratory Medicine 219
- Pharmaceutical Science 36
- Speech and Hearing 19
- Molecular Medicine 15
- Critical Care and Intensive Care Medicine 12
Countries citing papers authored by Paul Bruinenberg
This map shows the geographic impact of Paul Bruinenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Bruinenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Bruinenberg more than expected).
Fields of papers citing papers by Paul Bruinenberg
This network shows the impact of papers produced by Paul Bruinenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Bruinenberg. The network helps show where Paul Bruinenberg may publish in the future.
Co-authors
The 23 scholars most cited alongside Paul Bruinenberg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 181 | |
| 2 | 2009 | 15 | |
| 3 | 2022 | 12 | |
| 4 | Multicenter, randomized, double-blind, placebo-controlled study (ORBIT 1) to evaluate the efficacy, safety, and tolerability of once daily ciprofloxacin for inhalation in the management of pseudomonas aeruginosa infections in patients with non-cystic fibrosis bronchiectasis | 2011 | 12 |
| 5 | 2009 | 10 | |
| 6 | 2010 | 9 | |
| 7 | Dual release ciprofloxacin for inhalation (DRCFI) reduces sputum pseudomonas aeruginosa (Pa) density and delays time to infective pulmonary exacerbation in non-cystic fibrosis (CF) bronchiectasis (BE) | 2011 | 5 |
| 8 | Safety, tolerability, pharmacokinetics and antimicrobial activity of inhaled liposomal ciprofloxacin formulations in humans | 2010 | 3 |
| 9 | 2024 | 3 | |
| 10 | 2025 | 3 | |
| 11 | 2010 | 3 | |
| 12 | 2011 | 2 | |
| 13 | 2011 | 1 | |
| 14 | 2016 | 1 | |
| 15 | 2025 | 0 |
About Paul Bruinenberg
Paul Bruinenberg is a scholar working on Pulmonary and Respiratory Medicine, Pharmacology, Infectious Diseases, Pediatrics, Perinatology and Child Health and Speech and Hearing, having authored 15 papers that have together received 260 indexed citations. Recurring topics across this work include Cystic Fibrosis Research Advances (10 papers), Inhalation and Respiratory Drug Delivery (7 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers), Neonatal Respiratory Health Research (3 papers), Tuberculosis Research and Epidemiology (2 papers), Dysphagia Assessment and Management (2 papers), Pediatric health and respiratory diseases (2 papers) and Pharmaceutical studies and practices (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (219 citations), Pharmaceutical Science (36 citations), Speech and Hearing (19 citations), Molecular Medicine (15 citations) and Critical Care and Intensive Care Medicine (12 citations). Paul Bruinenberg has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include David J. Serisier, Diana Bilton, David Cipolla, John Kolbe, Hugh Greville, Anthony De Soyza, Igor Gonda, Philip J. Thompson, Jim Blanchard and Babatunde Otulana. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Journal of Cystic Fibrosis, British Journal of Clinical Pharmacology, Thorax and Pneumologie.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.